Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis.

Posselt G, Wiesauer M, Chichirau BE, Engler D, Krisch LM, Gadermaier G, Briza P, Schneider S, Boccellato F, Meyer TF, Hauser-Kronberger C, Neureiter D, Müller A, Wessler S.

Cell Commun Signal. 2019 Jan 31;17(1):10. doi: 10.1186/s12964-019-0323-9.

2.

Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection.

Boccellato F, Woelffling S, Imai-Matsushima A, Sanchez G, Goosmann C, Schmid M, Berger H, Morey P, Denecke C, Ordemann J, Meyer TF.

Gut. 2018 Feb 21. pii: gutjnl-2017-314540. doi: 10.1136/gutjnl-2017-314540. [Epub ahead of print]

3.

Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.

Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, Dyer V, Koch M, Mollenkopf HJ, Schlaermann P, Meyer TF.

Gastroenterology. 2018 Apr;154(5):1391-1404.e9. doi: 10.1053/j.gastro.2017.12.008. Epub 2017 Dec 19.

4.

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Roggenbuck D, Borghi MO, Somma V, Büttner T, Schierack P, Hanack K, Grossi C, Bodio C, Macor P, von Landenberg P, Boccellato F, Mahler M, Meroni PL.

Arthritis Res Ther. 2016 May 21;18(1):111. doi: 10.1186/s13075-016-1018-x.

5.

Bacteria Moving into Focus of Human Cancer.

Boccellato F, Meyer TF.

Cell Host Microbe. 2015 Jun 10;17(6):728-30. doi: 10.1016/j.chom.2015.05.016.

6.

Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.

Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, Severa M, Coccia EM, Bigi R, Cirone M, Ferretti E, Campese AF, Hummel M, Frati L, Presutti C, Faggioni A, Trivedi P.

Leukemia. 2012 Nov;26(11):2343-52. doi: 10.1038/leu.2012.108. Epub 2012 Apr 19.

7.

Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.

Anastasiadou E, Boccellato F, Vincenti S, Rosato P, Bozzoni I, Frati L, Faggioni A, Presutti C, Trivedi P.

Oncogene. 2010 Mar 4;29(9):1316-28. doi: 10.1038/onc.2009.439. Epub 2009 Dec 7.

PMID:
19966860
8.

Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells.

Anastasiadou E, Vaeth S, Cuomo L, Boccellato F, Vincenti S, Cirone M, Presutti C, Junker S, Winberg G, Frati L, Wade PA, Faggioni A, Trivedi P.

Cancer Lett. 2009 Nov 1;284(2):165-74. doi: 10.1016/j.canlet.2009.04.025. Epub 2009 May 28.

PMID:
19481340
9.

EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, Trivedi P.

J Virol. 2007 Mar;81(5):2274-82. Epub 2006 Dec 6.

10.

Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus.

Anastasiadou E, Boccellato F, Cirone M, Kis LL, Klein E, Frati L, Faggioni A, Trivedi P.

Leukemia. 2005 Oct;19(10):1854-6. No abstract available.

PMID:
16079894

Supplemental Content

Loading ...
Support Center